Atossa Therapeutics
ATOS
#9333
Rank
โ‚น8.37 B
Marketcap
โ‚น64.83
Share price
-13.37%
Change (1 day)
-28.56%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น4.51 Billion

According to Atossa Therapeutics's latest financial reports the company has โ‚น4.51 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น6.13 B-19.07%
2023-12-31$โ‚น7.57 B-22.38%
2022-12-31$โ‚น9.76 B-5.06%
2021-12-31$โ‚น10.28 B417.47%
2020-12-31$โ‚น1.98 B111.79%
2019-12-31$โ‚น0.93 B52.38%
2018-12-31$โ‚น0.61 B38.96%
2017-12-31$โ‚น0.44 B110.51%
2016-12-31$โ‚น0.21 B-15.36%
2015-12-31$โ‚น0.24 B-58.69%
2014-12-31$โ‚น0.60 B-8.09%
2013-12-31$โ‚น0.65 B131.13%
2012-12-31$โ‚น0.28 B243.45%
2011-12-31$โ‚น82.5 M-316.15%
2010-12-31$-โ‚น38.18 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚น7.190 T 159,132.33%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น790.32 B 17,400.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น669.04 B 14,715.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น3.93 B-12.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น76.03 B 1,583.75%๐Ÿ‡บ๐Ÿ‡ธ USA